Association of Urinary Phthalates with Self-Reported Eye Affliction/Retinopathy in Individuals with Diabetes: National Health and Nutrition Examination Survey, 2001–2010

Table 2

Univariate association of urinary phthalate metabolites with self-reported eye affliction/retinopathy in participants with diabetes, NHANES 2001–2010.

Phthalate	OR	95% CI
Mono-n-butyl (MBP)	1.12	0.90–1.39	0.285	1.000
Mono-cyclohexyl (MCP)	1.28	0.99–1.63	0.053	0.636
Mono-ethyl (MEP)	1.08	0.83–1.40	0.583	1.000
Mono-(2-ethyl)-hexyl (MEHP)	1.02	0.83–1.25	0.860	1.000
Mono-isononyl (MNP)	1.19	0.95–1.49	0.120	1.000
Mono-n-octyl (MOP)	1.39	1.11–1.74	0.004	0.048
Mono-benzyl (MBzP)	1.20	0.91–1.57	0.196	1.000
Mono-n-methyl (MNM)	1.10	0.85–1.42	0.455	1.000
Mono-(3-carboxypropyl) (MCPP)	1.01	0.83–1.24	0.893	1.000
Mono-(2-ethyl-5-hydroxyhexyl) (MEHHP)	1.17	0.93–1.46	0.176	1.000
Mono-(2-ethyl-5-oxohexyl) (MEOHP)	1.22	0.97–1.54	0.084	1.000
Mono-isobutyl (MiBP)	1.14	0.90–1.45	0.278	1.000

All models account for the survey design variables using svy command in Stata and use inverse-normalized concentrations of phthalate metabolites.
Results are from separate logistic regression models for each phthalate metabolite.
: nominal significance value; : Bonferroni-corrected significance value.